Stock overview
Intellia Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
INTELLIA THERAPEUTICS INC (NTLA) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $11.75
- · NTLA
- Tracked holders
- 4 funds
- Latest available 13F per fund
NTLA · USD
Price
$11.75
-$4.86
(-29.26%)
over selected range
Close · Sep 25, 2026
Market closed
252 stored daily closes
$11.75
Sep 25, 2026
- Range low
- $8.04
- Range high
- $27.98
- Observations
- 252
- Session date
- Sep 25, 2026
Sep 25, 2025–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| ARK Investment Management largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | +16% 26'Q2 | $285,536,575 | 1.85% |
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | Newly reported 26'Q2 | $23,688,068 | 0.03% |
| Baker Bros. Advisors position history Q2 2026 · filed Aug 14, 2026 · SEC filing | Newly reported 26'Q2 | $15,739,525 | 0.08% |
| Tudor Investment Corp position history Q2 2026 · filed Aug 14, 2026 · SEC filing | +31% 26'Q2 | $1,978,083 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market